 | • レポートコード：B-GIR08C3995 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、神経内分泌腫瘍（NET）治療の世界市場について調べ、まとめました。種類別セグメントは、ソマトスタチンアナログ（SSA）、標的療法、その他等、用途別セグメントは、病院、診療所、その他等に区分しました。神経内分泌腫瘍（NET）治療の世界市場概観、企業動向、企業別神経内分泌腫瘍（NET）治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・神経内分泌腫瘍（NET）治療の市場概観 ・神経内分泌腫瘍（NET）治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・神経内分泌腫瘍（NET）治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・神経内分泌腫瘍（NET）治療の世界市場規模 ・神経内分泌腫瘍（NET）治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・神経内分泌腫瘍（NET）治療のアメリカ市場規模推移 ・神経内分泌腫瘍（NET）治療のカナダ市場規模推移 ・神経内分泌腫瘍（NET）治療のメキシコ市場規模推移 ・神経内分泌腫瘍（NET）治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・神経内分泌腫瘍（NET）治療のドイツ市場規模推移 ・神経内分泌腫瘍（NET）治療のイギリス市場規模推移 ・神経内分泌腫瘍（NET）治療のロシア市場規模推移 ・神経内分泌腫瘍（NET）治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・神経内分泌腫瘍（NET）治療の日本市場規模推移 ・神経内分泌腫瘍（NET）治療の中国市場規模推移 ・神経内分泌腫瘍（NET）治療の韓国市場規模推移 ・神経内分泌腫瘍（NET）治療のインド市場規模推移 ・神経内分泌腫瘍（NET）治療の東南アジア市場規模推移 ・神経内分泌腫瘍（NET）治療の南米市場分析（ブラジル、アルゼンチン等） ・神経内分泌腫瘍（NET）治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・神経内分泌腫瘍（NET）治療の種類別分析/販売量、売上、市場シェア（ソマトスタチンアナログ（SSA）、標的療法、その他） ・神経内分泌腫瘍（NET）治療の用途別分析/市場規模（病院、診療所、その他） ・神経内分泌腫瘍（NET）治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・神経内分泌腫瘍（NET）治療の販売チャネル・代理店・貿易業者・ディーラー分析 |
Neuro Emotional Technique (NET) is a psycho-emotional therapy based on the physiological foundations of stress-related responses. As discovered in the late 1970’s, emotional responses are composed of neuropeptides (amino acid chains) and their receptors, which lie on neurons and other cells of remote tissues in the body. The neuropeptides are ejected from the neuron and carry the encoded “information” to other sites within the body. These neuropeptides are in a category of neurochemicals known as Information Substances (IS). ISs are released at times of stress-related arousal and become attached to remotely-positioned neuroreceptors.
Scope of the Report:
The worldwide market for Neuroendocrine Tumors (NETs) Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Neuroendocrine Tumors (NETs) Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Advanced Accelerator Applications
AVEO Oncology
Boehringer Ingelheim International
Hutchison MediPharma Limited
IpsenPharma
Novartis AG
Pfizer, Inc
Progenics Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Somatostatin Analogs (SSAs)
Targeted Therapy
Other
Market Segment by Applications, can be divided into
Hospitals
Clinics
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neuroendocrine Tumors (NETs) Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neuroendocrine Tumors (NETs) Treatment, with price, sales, revenue and global market share of Neuroendocrine Tumors (NETs) Treatment in 2017 and 2018.
Chapter 3, the Neuroendocrine Tumors (NETs) Treatment competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neuroendocrine Tumors (NETs) Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Neuroendocrine Tumors (NETs) Treatment market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Neuroendocrine Tumors (NETs) Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Neuroendocrine Tumors (NETs) Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Somatostatin Analogs (SSAs)
1.2.2 Targeted Therapy
1.2.3 Other
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Advanced Accelerator Applications
2.1.1 Business Overview
2.1.2 Neuroendocrine Tumors (NETs) Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Advanced Accelerator Applications Neuroendocrine Tumors (NETs) Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 AVEO Oncology
2.2.1 Business Overview
2.2.2 Neuroendocrine Tumors (NETs) Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AVEO Oncology Neuroendocrine Tumors (NETs) Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Boehringer Ingelheim International
2.3.1 Business Overview
2.3.2 Neuroendocrine Tumors (NETs) Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Boehringer Ingelheim International Neuroendocrine Tumors (NETs) Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Hutchison MediPharma Limited
2.4.1 Business Overview
2.4.2 Neuroendocrine Tumors (NETs) Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Hutchison MediPharma Limited Neuroendocrine Tumors (NETs) Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 IpsenPharma
2.5.1 Business Overview
2.5.2 Neuroendocrine Tumors (NETs) Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 IpsenPharma Neuroendocrine Tumors (NETs) Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Novartis AG
2.6.1 Business Overview
2.6.2 Neuroendocrine Tumors (NETs) Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis AG Neuroendocrine Tumors (NETs) Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Pfizer, Inc
2.7.1 Business Overview
2.7.2 Neuroendocrine Tumors (NETs) Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer, Inc Neuroendocrine Tumors (NETs) Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Progenics Pharmaceuticals
2.8.1 Business Overview
2.8.2 Neuroendocrine Tumors (NETs) Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Progenics Pharmaceuticals Neuroendocrine Tumors (NETs) Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Neuroendocrine Tumors (NETs) Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Neuroendocrine Tumors (NETs) Treatment Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Neuroendocrine Tumors (NETs) Treatment Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Neuroendocrine Tumors (NETs) Treatment Manufacturer Market Share in 2018
3.3.2 Top 6 Neuroendocrine Tumors (NETs) Treatment Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Neuroendocrine Tumors (NETs) Treatment Market Analysis by Regions
4.1 Global Neuroendocrine Tumors (NETs) Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global Neuroendocrine Tumors (NETs) Treatment Sales and Market Share by Regions (2014-2019)
4.1.2 Global Neuroendocrine Tumors (NETs) Treatment Revenue and Market Share by Regions (2014-2019)
4.2 North America Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
4.3 Europe Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
4.5 South America Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
5 North America Neuroendocrine Tumors (NETs) Treatment by Country
5.1 North America Neuroendocrine Tumors (NETs) Treatment Sales, Revenue and Market Share by Country
5.1.1 North America Neuroendocrine Tumors (NETs) Treatment Sales and Market Share by Country (2014-2019)
5.1.2 North America Neuroendocrine Tumors (NETs) Treatment Revenue and Market Share by Country (2014-2019)
5.2 United States Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
5.3 Canada Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
5.4 Mexico Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
6 Europe Neuroendocrine Tumors (NETs) Treatment by Country
6.1 Europe Neuroendocrine Tumors (NETs) Treatment Sales, Revenue and Market Share by Country
6.1.1 Europe Neuroendocrine Tumors (NETs) Treatment Sales and Market Share by Country (2014-2019)
6.1.2 Europe Neuroendocrine Tumors (NETs) Treatment Revenue and Market Share by Country (2014-2019)
6.2 Germany Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
6.3 UK Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
6.4 France Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
6.5 Russia Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
6.6 Italy Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
7 Asia-Pacific Neuroendocrine Tumors (NETs) Treatment by Country
7.1 Asia-Pacific Neuroendocrine Tumors (NETs) Treatment Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Neuroendocrine Tumors (NETs) Treatment Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Neuroendocrine Tumors (NETs) Treatment Revenue and Market Share by Country (2014-2019)
7.2 China Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
7.3 Japan Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
7.4 Korea Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
7.5 India Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
8 South America Neuroendocrine Tumors (NETs) Treatment by Country
8.1 South America Neuroendocrine Tumors (NETs) Treatment Sales, Revenue and Market Share by Country
8.1.1 South America Neuroendocrine Tumors (NETs) Treatment Sales and Market Share by Country (2014-2019)
8.1.2 South America Neuroendocrine Tumors (NETs) Treatment Revenue and Market Share by Country (2014-2019)
8.2 Brazil Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
8.3 Argentina Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
8.4 Colombia Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
9 Middle East and Africa Neuroendocrine Tumors (NETs) Treatment by Countries
9.1 Middle East and Africa Neuroendocrine Tumors (NETs) Treatment Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Neuroendocrine Tumors (NETs) Treatment Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Neuroendocrine Tumors (NETs) Treatment Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
9.3 Turkey Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
9.4 Egypt Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
9.5 Nigeria Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
9.6 South Africa Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
10 Global Neuroendocrine Tumors (NETs) Treatment Market Segment by Type
10.1 Global Neuroendocrine Tumors (NETs) Treatment Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Neuroendocrine Tumors (NETs) Treatment Sales and Market Share by Type (2014-2019)
10.1.2 Global Neuroendocrine Tumors (NETs) Treatment Revenue and Market Share by Type (2014-2019)
10.2 Somatostatin Analogs (SSAs) Sales Growth and Price
10.2.1 Global Somatostatin Analogs (SSAs) Sales Growth (2014-2019)
10.2.2 Global Somatostatin Analogs (SSAs) Price (2014-2019)
10.3 Targeted Therapy Sales Growth and Price
10.3.1 Global Targeted Therapy Sales Growth (2014-2019)
10.3.2 Global Targeted Therapy Price (2014-2019)
10.4 Other Sales Growth and Price
10.4.1 Global Other Sales Growth (2014-2019)
10.4.2 Global Other Price (2014-2019)
11 Global Neuroendocrine Tumors (NETs) Treatment Market Segment by Application
11.1 Global Neuroendocrine Tumors (NETs) Treatment Sales Market Share by Application (2014-2019)
11.2 Hospitals Sales Growth (2014-2019)
11.3 Clinics Sales Growth (2014-2019)
11.4 Other Sales Growth (2014-2019)
12 Neuroendocrine Tumors (NETs) Treatment Market Forecast (2019-2024)
12.1 Global Neuroendocrine Tumors (NETs) Treatment Sales, Revenue and Growth Rate (2019-2024)
12.2 Neuroendocrine Tumors (NETs) Treatment Market Forecast by Regions (2019-2024)
12.2.1 North America Neuroendocrine Tumors (NETs) Treatment Market Forecast (2019-2024)
12.2.2 Europe Neuroendocrine Tumors (NETs) Treatment Market Forecast (2019-2024)
12.2.3 Asia-Pacific Neuroendocrine Tumors (NETs) Treatment Market Forecast (2019-2024)
12.2.4 South America Neuroendocrine Tumors (NETs) Treatment Market Forecast (2019-2024)
12.2.5 Middle East and Africa Neuroendocrine Tumors (NETs) Treatment Market Forecast (2019-2024)
12.3 Neuroendocrine Tumors (NETs) Treatment Market Forecast by Type (2019-2024)
12.3.1 Global Neuroendocrine Tumors (NETs) Treatment Sales Forecast by Type (2019-2024)
12.3.2 Global Neuroendocrine Tumors (NETs) Treatment Market Share Forecast by Type (2019-2024)
12.4 Neuroendocrine Tumors (NETs) Treatment Market Forecast by Application (2019-2024)
12.4.1 Global Neuroendocrine Tumors (NETs) Treatment Sales Forecast by Application (2019-2024)
12.4.2 Global Neuroendocrine Tumors (NETs) Treatment Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Neuroendocrine Tumors (NETs) Treatment Picture
Table Product Specifications of Neuroendocrine Tumors (NETs) Treatment
Figure Global Sales Market Share of Neuroendocrine Tumors (NETs) Treatment by Types in 2018
Table Neuroendocrine Tumors (NETs) Treatment Types for Major Manufacturers
Figure Somatostatin Analogs (SSAs) Picture
Figure Targeted Therapy Picture
Figure Other Picture
Figure Neuroendocrine Tumors (NETs) Treatment Sales Market Share by Applications in 2018
Figure Hospitals Picture
Figure Clinics Picture
Figure Other Picture
Figure United States Neuroendocrine Tumors (NETs) Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Neuroendocrine Tumors (NETs) Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Neuroendocrine Tumors (NETs) Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Neuroendocrine Tumors (NETs) Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure France Neuroendocrine Tumors (NETs) Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure UK Neuroendocrine Tumors (NETs) Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Neuroendocrine Tumors (NETs) Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Neuroendocrine Tumors (NETs) Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure China Neuroendocrine Tumors (NETs) Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Neuroendocrine Tumors (NETs) Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Neuroendocrine Tumors (NETs) Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure India Neuroendocrine Tumors (NETs) Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Neuroendocrine Tumors (NETs) Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Neuroendocrine Tumors (NETs) Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Neuroendocrine Tumors (NETs) Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Neuroendocrine Tumors (NETs) Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Neuroendocrine Tumors (NETs) Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Neuroendocrine Tumors (NETs) Treatment Revenue (Value) and Growth Rate (2014-2024)
Table Advanced Accelerator Applications Basic Information, Manufacturing Base and Competitors
Table Advanced Accelerator Applications Neuroendocrine Tumors (NETs) Treatment Type and Applications
Table Advanced Accelerator Applications Neuroendocrine Tumors (NETs) Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table AVEO Oncology Basic Information, Manufacturing Base and Competitors
Table AVEO Oncology Neuroendocrine Tumors (NETs) Treatment Type and Applications
Table AVEO Oncology Neuroendocrine Tumors (NETs) Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Boehringer Ingelheim International Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim International Neuroendocrine Tumors (NETs) Treatment Type and Applications
Table Boehringer Ingelheim International Neuroendocrine Tumors (NETs) Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Hutchison MediPharma Limited Basic Information, Manufacturing Base and Competitors
Table Hutchison MediPharma Limited Neuroendocrine Tumors (NETs) Treatment Type and Applications
Table Hutchison MediPharma Limited Neuroendocrine Tumors (NETs) Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table IpsenPharma Basic Information, Manufacturing Base and Competitors
Table IpsenPharma Neuroendocrine Tumors (NETs) Treatment Type and Applications
Table IpsenPharma Neuroendocrine Tumors (NETs) Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Neuroendocrine Tumors (NETs) Treatment Type and Applications
Table Novartis AG Neuroendocrine Tumors (NETs) Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer, Inc Basic Information, Manufacturing Base and Competitors
Table Pfizer, Inc Neuroendocrine Tumors (NETs) Treatment Type and Applications
Table Pfizer, Inc Neuroendocrine Tumors (NETs) Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Progenics Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Progenics Pharmaceuticals Neuroendocrine Tumors (NETs) Treatment Type and Applications
Table Progenics Pharmaceuticals Neuroendocrine Tumors (NETs) Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Neuroendocrine Tumors (NETs) Treatment Sales by Manufacturer (2017-2018)
Figure Global Neuroendocrine Tumors (NETs) Treatment Sales Market Share by Manufacturer in 2017
Figure Global Neuroendocrine Tumors (NETs) Treatment Sales Market Share by Manufacturer in 2018
Table Global Neuroendocrine Tumors (NETs) Treatment Revenue by Manufacturer (2017-2018)
Figure Global Neuroendocrine Tumors (NETs) Treatment Revenue Market Share by Manufacturer in 2017
Figure Global Neuroendocrine Tumors (NETs) Treatment Revenue Market Share by Manufacturer in 2018
Figure Top 3 Neuroendocrine Tumors (NETs) Treatment Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Neuroendocrine Tumors (NETs) Treatment Manufacturer (Revenue) Market Share in 2018
Figure Global Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
Figure Global Neuroendocrine Tumors (NETs) Treatment Revenue and Growth Rate (2014-2019)
Table Global Neuroendocrine Tumors (NETs) Treatment Sales by Regions (2014-2019)
Table Global Neuroendocrine Tumors (NETs) Treatment Sales Market Share by Regions (2014-2019)
Table Global Neuroendocrine Tumors (NETs) Treatment Revenue by Regions (2014-2019)
Figure Global Neuroendocrine Tumors (NETs) Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Neuroendocrine Tumors (NETs) Treatment Revenue Market Share by Regions in 2018
Figure North America Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
Figure Europe Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
Figure South America Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
Figure North America Neuroendocrine Tumors (NETs) Treatment Revenue and Growth Rate (2014-2019)
Table North America Neuroendocrine Tumors (NETs) Treatment Sales by Countries (2014-2019)
Table North America Neuroendocrine Tumors (NETs) Treatment Sales Market Share by Countries (2014-2019)
Figure North America Neuroendocrine Tumors (NETs) Treatment Sales Market Share by Countries (2014-2019)
Figure North America Neuroendocrine Tumors (NETs) Treatment Sales Market Share by Countries in 2018
Table North America Neuroendocrine Tumors (NETs) Treatment Revenue by Countries (2014-2019)
Table North America Neuroendocrine Tumors (NETs) Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Neuroendocrine Tumors (NETs) Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Neuroendocrine Tumors (NETs) Treatment Revenue Market Share by Countries in 2018
Figure United States Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
Figure Canada Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
Figure Mexico Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
Figure Europe Neuroendocrine Tumors (NETs) Treatment Revenue and Growth Rate (2014-2019)
Table Europe Neuroendocrine Tumors (NETs) Treatment Sales by Countries (2014-2019)
Table Europe Neuroendocrine Tumors (NETs) Treatment Sales Market Share by Countries (2014-2019)
Table Europe Neuroendocrine Tumors (NETs) Treatment Revenue by Countries (2014-2019)
Figure Europe Neuroendocrine Tumors (NETs) Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Neuroendocrine Tumors (NETs) Treatment Revenue Market Share by Countries in 2018
Figure Germany Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
Figure UK Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
Figure France Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
Figure Russia Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
Figure Italy Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Neuroendocrine Tumors (NETs) Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Neuroendocrine Tumors (NETs) Treatment Sales by Countries (2014-2019)
Table Asia-Pacific Neuroendocrine Tumors (NETs) Treatment Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Neuroendocrine Tumors (NETs) Treatment Sales Market Share by Countries 2018
Table Asia-Pacific Neuroendocrine Tumors (NETs) Treatment Revenue by Countries (2014-2019)
Figure Asia-Pacific Neuroendocrine Tumors (NETs) Treatment Revenue Market Share by Countries 2018
Figure China Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
Figure Japan Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
Figure Korea Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
Figure India Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
Figure Southeast Asia Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
Figure South America Neuroendocrine Tumors (NETs) Treatment Revenue and Growth Rate (2014-2019)
Table South America Neuroendocrine Tumors (NETs) Treatment Sales by Countries (2014-2019)
Table South America Neuroendocrine Tumors (NETs) Treatment Sales Market Share by Countries (2014-2019)
Figure South America Neuroendocrine Tumors (NETs) Treatment Sales Market Share by Countries in 2018
Table South America Neuroendocrine Tumors (NETs) Treatment Revenue by Countries (2014-2019)
Table South America Neuroendocrine Tumors (NETs) Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Neuroendocrine Tumors (NETs) Treatment Revenue Market Share by Countries in 2018
Figure Brazil Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
Figure Argentina Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
Figure Colombia Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Neuroendocrine Tumors (NETs) Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Neuroendocrine Tumors (NETs) Treatment Sales by Countries (2014-2019)
Table Middle East and Africa Neuroendocrine Tumors (NETs) Treatment Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Neuroendocrine Tumors (NETs) Treatment Sales Market Share by Countries in 2018
Table Middle East and Africa Neuroendocrine Tumors (NETs) Treatment Revenue by Countries (2014-2019)
Table Middle East and Africa Neuroendocrine Tumors (NETs) Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Neuroendocrine Tumors (NETs) Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Neuroendocrine Tumors (NETs) Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
Figure UAE Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
Figure Egypt Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
Figure Nigeria Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
Figure South Africa Neuroendocrine Tumors (NETs) Treatment Sales and Growth Rate (2014-2019)
Table Global Neuroendocrine Tumors (NETs) Treatment Sales by Type (2014-2019)
Table Global Neuroendocrine Tumors (NETs) Treatment Sales Share by Type (2014-2019)
Table Global Neuroendocrine Tumors (NETs) Treatment Revenue by Type (2014-2019)
Table Global Neuroendocrine Tumors (NETs) Treatment Revenue Share by Type (2014-2019)
Figure Global Somatostatin Analogs (SSAs) Sales Growth (2014-2019)
Figure Global Somatostatin Analogs (SSAs) Price (2014-2019)
Figure Global Targeted Therapy Sales Growth (2014-2019)
Figure Global Targeted Therapy Price (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Other Price (2014-2019)
Table Global Neuroendocrine Tumors (NETs) Treatment Sales by Application (2014-2019)
Table Global Neuroendocrine Tumors (NETs) Treatment Sales Share by Application (2014-2019)
Figure Global Clinics Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Neuroendocrine Tumors (NETs) Treatment Sales, Revenue and Growth Rate (2019-2024)
Table Global Neuroendocrine Tumors (NETs) Treatment Sales Forecast by Regions (2019-2024)
Table Global Neuroendocrine Tumors (NETs) Treatment Market Share Forecast by Regions (2019-2024)
Figure North America Sales Neuroendocrine Tumors (NETs) Treatment Market Forecast (2019-2024)
Figure Europe Sales Neuroendocrine Tumors (NETs) Treatment Market Forecast (2019-2024)
Figure Asia-Pacific Sales Neuroendocrine Tumors (NETs) Treatment Market Forecast (2019-2024)
Figure South America Sales Neuroendocrine Tumors (NETs) Treatment Market Forecast (2019-2024)
Figure Middle East and Africa Sales Neuroendocrine Tumors (NETs) Treatment Market Forecast (2019-2024)
Table Global Neuroendocrine Tumors (NETs) Treatment Sales Forecast by Type (2019-2024)
Table Global Neuroendocrine Tumors (NETs) Treatment Market Share Forecast by Type (2019-2024)
Table Global Neuroendocrine Tumors (NETs) Treatment Sales Forecast by Application (2019-2024)
Table Global Neuroendocrine Tumors (NETs) Treatment Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
小分子標的癌療法の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Small Molecule Targeted Cancer Therapy market is valued at million USD in 2018 and is expected to reach million USD by the end of 2024, growing at a CAGR of between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in Chi…- がん標的療法の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Cancer Targeted Therapy market is valued at million USD in 2018 and is expected to reach million USD by the end of 2024, growing at a CAGR of between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast g…
- ベッドネットの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Bed Nets is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Bed Nets in global market, especially in…
- 世界の神経内分泌機能検査市場：市場規模・現状・予測 Neuroendocrine function test is a diagnosis process of finding out the neuroendocrine tumor.Based on treatment type, the global neuroendocrine function test market is segmented surgery and medication. As surgery is widely used in the neuroendocrine function test market. Similarly, based on end user,…
- 癌用温熱療法の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Hyperthermia Treatment for Cancer market is valued at million USD in 2018 and is expected to reach million USD by the end of 2024, growing at a CAGR of between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, a…